NCT04087499

Brief Summary

Vascular cognitive impairment (VCI) is a broad dimensional term, ranging from mild cognitive impairment without incapacity on activity of daily living to vascular dementia (VaD), referred to as significant cognitive impairment and decline in function status. In this three-year project, we aim to evaluate the effects of biochemical data, early clinical variables, neuroimaging results, and intervention of acupuncture treatment on vascular event related cognitive impairment in crossectional analysis and longitudinal follow-up.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
80

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Sep 2019

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

August 18, 2019

Completed
14 days until next milestone

Study Start

First participant enrolled

September 1, 2019

Completed
11 days until next milestone

First Posted

Study publicly available on registry

September 12, 2019

Completed
12 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 1, 2020

Completed
1.8 years until next milestone

Study Completion

Last participant's last visit for all outcomes

July 1, 2022

Completed
Last Updated

October 3, 2019

Status Verified

August 1, 2019

Enrollment Period

1 year

First QC Date

August 18, 2019

Last Update Submit

October 1, 2019

Conditions

Outcome Measures

Primary Outcomes (1)

  • Change from baseline sleep quality at 3 months, 6 months, 12 months

    Analogous variables were extracted from actigraphy. The sleep variables collected were sleep start time, sleep end time, sleep duration, sleep efficiency, and wake after sleep onset time, and the activity variables collected were heart rate activity score,activity amount, and activity intensity

    3 months, 6 months, 12 months

Secondary Outcomes (12)

  • Change from baseline neuro-behavioral performances at 3 months, 6 months, 12 months

    3 months, 6 months, 12 months

  • Change from baseline motor function (UPDRS) at 3 months, 6 months, 12 months

    3 months, 6 months, 12 months

  • Change from baseline motor function (NIHSS) at 3 months, 6 months, 12 months

    3 months, 6 months, 12 months

  • Change from baseline continuous motor function at 3 months, 6 months, 12 months

    3 months, 6 months, 12 months

  • Change from baseline memory performances at 3 months, 6 months, 12 months

    3 months, 6 months, 12 months

  • +7 more secondary outcomes

Study Arms (2)

regular medication treatment

SHAM COMPARATOR

regular medication treatment

Device: Acupuncture

acupuncture and regular medication treatment

EXPERIMENTAL

acupuncture and regular medication treatment

Device: Acupuncture

Interventions

acupuncture treatment on selected acupoint

acupuncture and regular medication treatmentregular medication treatment

Eligibility Criteria

Age50 Years - 80 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • \. Fulfill the diagnostic criteria of vascular cognitive impairment

You may not qualify if:

  • Systemic inflammatory disease with on-going treatment
  • Severe psychiatric disease, such as major depressive disorder or schizophrenia
  • Severe traumatic brain injury
  • Unable to tolerate exam of brain MRI

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Kaohsiung Chang Gung Memorial Hospital

Kaohsiung City, 83301, Taiwan

RECRUITING

MeSH Terms

Interventions

Acupuncture Therapy

Intervention Hierarchy (Ancestors)

Complementary TherapiesTherapeutics

Study Officials

  • YaTing Chang, MD,PhD

    Chang Gung Memorial Hospital

    PRINCIPAL INVESTIGATOR

Central Study Contacts

YaTing Chang, MD,PhD

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
TRIPLE
Who Masked
PARTICIPANT, CARE PROVIDER, OUTCOMES ASSESSOR
Purpose
PREVENTION
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

August 18, 2019

First Posted

September 12, 2019

Study Start

September 1, 2019

Primary Completion

September 1, 2020

Study Completion

July 1, 2022

Last Updated

October 3, 2019

Record last verified: 2019-08

Data Sharing

IPD Sharing
Will not share

Locations